Safety of specific immunotherapy using a depigmented and polymerised extract of Dermatophagoides pteronyssinus in children under five years of age

Allergologia et Immunopathologia

Volumn 39, Issue 5, 2011, Pages 267-270

  Hernandez N ^a   Ibero, M ^a   Ridao, M ^a   Artigas, R ^a   Vinas M ^a   Castillo, M J ^a  

^a HOSPITAL DE TERRASSA   (Spain)

Author keywords

Adverse reactions; Children; Cluster protocol; Safety; Specific immunotherapy

Indexed keywords

DEPIGOID; GLUTARALDEHYDE; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; UNCLASSIFIED DRUG;

ALLERGIC RHINITIS; ARTICLE; ASTHMA; CHILD; CLINICAL PROTOCOL; CONTROLLED STUDY; COUGHING; DELAYED HYPERSENSITIVITY; DERMATOPHAGOIDES PTERONYSSINUS; DRUG CONTRAINDICATION; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; POLYMERIZATION; PRESCHOOL CHILD; PRICK TEST; RETROSPECTIVE STUDY; WHEEZING;

ANIMALS; ANTIGENS, DERMATOPHAGOIDES; ASTHMA; CHILD, PRESCHOOL; COMPLEX MIXTURES; DERMATOPHAGOIDES PTERONYSSINUS; DESENSITIZATION, IMMUNOLOGIC; FEMALE; FOLLOW-UP STUDIES; GLUTARAL; HUMANS; IMMUNOGLOBULIN E; INFANT; MALE; PIGMENTS, BIOLOGICAL; POLYMERIZATION; RETROSPECTIVE STUDIES; RHINITIS, ALLERGIC, PERENNIAL;

EID: 80053201701     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1016/j.aller.2010.09.002     Document Type: Article

References (19)

1. Bousquet J., Lockey R., Malling H.J. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998, 102:558-562.
2. Abramson MJ, Puy RM, Weiner JM. Immunotherapy con alérgenos for el asma (Revisión Cochrane traducida). In: La Biblioteca Cochrane Plus, 2005 Número 1. Oxford: Update Software Ltd. Disponible en: (Traducida de The Cochrane Library, 2005 Issue 1. Chichester, UK: John Wiley & Sons, Ltd. http://www.update-software.com/.
3. Calderon M.A. Meta-analyses of specific immunotherapy trials. Drugs of Today 2008, 44(Suppl. B):31-34.
4. Bousquet J., Lockey R.F., Malling H.-J., Alvarez_Cuesta E., Canonica G.W., Chapman M.D., et al. WHO Position Paper Allergen immunotherapy: Therapeutic vaccines for allergic diseases. Allergy 1998, 53(Suppl 44):1-42.
5. Jacobsen L., Niggemann B., Dreborg S., Ferdousi H.A., Halken S., Host A., et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007, 62:943-948.
6. Dennis R., Ownby D.R., Adinoff A.D. The appropriate use of skin testing and allergen immunotherapy in young children. J Allergy Clin Immunol 1994, 94:662-665.
7. Mailing H.J., Weeke B. EEACI Position paper: Immunotherapy. Allergy 1993, 48(14 Suppl):7-35.
8. Ibero M., Castillo M.J. Significant improvement of specific bronchial hyperreactivity in asthmatic children after 4 months of treatment with a modified extract of Dermatophagoides pteronyssinus. J Investig Allergol Clin Immunol 2006, 16:194-202.
9. Lockey R.F., Benedict M.L., Turkeltaub P.C., Bukantz S.C. Fatalities from immunotherapy (IT) and skin testing (ST). J Allergy Clin Immunol 1987, 79:660-677.
10. Hejjaoui A., Dhivert H., Michel F.B., Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract: IV Systemic reactions according to the immunotherapy schedule. J Allergy Clin Immunol 1990, 85:473-479.
11. Reid M.J., Lockey R.F., Turkeltaub P.C., Platts-Mills T.A.E. Fatalities (F) from immunotherapy (IT) and skin testing (ST). J Allergy Clin Immunol 1990, 85:180.
12. Des Roches A., Paradis L., Menardo J.-L., Bouges S., Daurés J.-P., Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 1997, 99:450-453.
13. Schubert R., Eickmeier O., Gran H., Baer P.C., Mueller T., Schulze J., et al. Safety and Immunogenicity of a Cluster Specific Immunotherapy in Children with Bronchial Asthma and Mite Allergy. Int Arch Allergy Immunol 2009, 148:251-260.
14. Álvarez Cuesta A.N.D., Aragoneses Gilsanz A.N.D., Martín García C., Berges Gimeno P., González Mancebo A.N.D., Cuesta Herranz J. Immunotherapy with despigmented glutaraldehyde-polymerized extracts: changes in quality of life. Clin Exp Allergy 2005, 35:572-578.
15. Ameal A., Vega-Chicote J.M., Fernández S., Miranda A., Carmona M.J., Rondon M.C., et al. Double-blind and placebo-controlled study to assess efficacy and safety of a modified allergen extract of Dermatophagoides pteronyssinus in allergic asthma. Allergy 2005, 60:1178-1183.
16. Branco Ferreira M., Spínola Santos A., Pereira Santos M.C., Palma Carlos M.L., Pereira Barbosa M.A., Palma Carlos A.G. Efficacy and safety of specific immunotherapy with a modified mite extract. Allergol et Immunopathol 2005, 33:80-85.
17. Paniagua M.J., Bosque M., Asensio O., Larramona H., Marco M.T. Immunotherapy con un extract de ácaros en children menores de cinco años. Allergol et Immunopathol 2002, 30:20-24.
18. Pajno G.B., Barberio G., De Luca F., Morabito L., Parmiani S. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 2001, 31:1392-1397.
19. Reha C.M., Ebru A. Specific immunotherapy is effective in the prevention of new sensitivities. Allergol et Immunopathol 2007, 35:44-51.